PT3952858T - Método de tratamento de tumores - Google Patents
Método de tratamento de tumoresInfo
- Publication number
- PT3952858T PT3952858T PT207871435T PT20787143T PT3952858T PT 3952858 T PT3952858 T PT 3952858T PT 207871435 T PT207871435 T PT 207871435T PT 20787143 T PT20787143 T PT 20787143T PT 3952858 T PT3952858 T PT 3952858T
- Authority
- PT
- Portugal
- Prior art keywords
- treatment method
- tumor treatment
- tumor
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2019901280A AU2019901280A0 (en) | 2019-04-12 | Method of Treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3952858T true PT3952858T (pt) | 2026-02-26 |
Family
ID=72752169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT207871435T PT3952858T (pt) | 2019-04-12 | 2020-04-09 | Método de tratamento de tumores |
Country Status (26)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1971588T3 (da) * | 2005-12-23 | 2012-10-22 | Qbiotics Ltd | Tiglien-3-onderivater |
| JP7013753B2 (ja) * | 2017-09-15 | 2022-02-01 | 株式会社三洋物産 | 遊技機 |
| BR112021024716A2 (pt) | 2019-06-19 | 2022-02-08 | QBiotics Pty Ltd | Ruptura de biofilme |
| CN118451065A (zh) * | 2021-12-21 | 2024-08-06 | Q生物股份有限公司 | 结晶中间体 |
| EP4638430A4 (en) * | 2022-12-21 | 2026-07-01 | QBiotics Pty Ltd | CRYSTALLINE FORMS AND THEIR PRODUCTION PROCESSES |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1971588T3 (da) * | 2005-12-23 | 2012-10-22 | Qbiotics Ltd | Tiglien-3-onderivater |
| PT2986615T (pt) | 2013-04-18 | 2019-03-22 | Qbiotics Ltd | Métodos e composições para a cicatrização de feridas |
| EP3490547A4 (en) * | 2016-07-28 | 2020-04-01 | QBiotics Pty Ltd | TREATMENT METHOD |
| SG11201907891XA (en) * | 2017-03-23 | 2019-09-27 | QBiotics Pty Ltd | Combination therapy for the treatment or prevention of tumours |
-
2020
- 2020-04-09 PL PL20787143.5T patent/PL3952858T3/pl unknown
- 2020-04-09 EP EP20787143.5A patent/EP3952858B1/en active Active
- 2020-04-09 BR BR112021020253A patent/BR112021020253A2/pt unknown
- 2020-04-09 IL IL287210A patent/IL287210B2/en unknown
- 2020-04-09 CN CN202080042217.2A patent/CN113924091A/zh active Pending
- 2020-04-09 AU AU2020256847A patent/AU2020256847B2/en active Active
- 2020-04-09 US US17/602,909 patent/US12226391B2/en active Active
- 2020-04-09 FI FIEP20787143.5T patent/FI3952858T3/fi active
- 2020-04-09 CA CA3136216A patent/CA3136216C/en active Active
- 2020-04-09 WO PCT/AU2020/050360 patent/WO2020206504A1/en not_active Ceased
- 2020-04-09 EA EA202192757A patent/EA202192757A1/ru unknown
- 2020-04-09 SI SI202030731T patent/SI3952858T1/sl unknown
- 2020-04-09 LT LTEPPCT/AU2020/050360T patent/LT3952858T/lt unknown
- 2020-04-09 ES ES20787143T patent/ES3063750T3/es active Active
- 2020-04-09 SG SG11202110599RA patent/SG11202110599RA/en unknown
- 2020-04-09 HR HRP20260232TT patent/HRP20260232T1/hr unknown
- 2020-04-09 RS RS20260210A patent/RS67777B1/sr unknown
- 2020-04-09 MX MX2021012449A patent/MX2021012449A/es unknown
- 2020-04-09 PT PT207871435T patent/PT3952858T/pt unknown
- 2020-04-09 JP JP2021559659A patent/JP7900152B2/ja active Active
- 2020-04-09 UA UAA202106322A patent/UA129840C2/uk unknown
- 2020-04-09 SM SM20260066T patent/SMT202600066T1/it unknown
- 2020-04-09 MY MYPI2021005947A patent/MY208979A/en unknown
- 2020-04-09 KR KR1020217036942A patent/KR20210152531A/ko active Pending
- 2020-04-09 DK DK20787143.5T patent/DK3952858T3/da active
-
2021
- 2021-11-05 ZA ZA2021/08677A patent/ZA202108677B/en unknown
-
2024
- 2024-12-27 JP JP2024231893A patent/JP2025060945A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL269026A (en) | Methods of treating tumor | |
| IL282794A (en) | Therapeutic methods | |
| IL283838A (en) | Method of treating cancer with a cancer therapy in combination with another therapeutic agent | |
| IL285771A (en) | Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator | |
| IL285847A (en) | Methods for treating map3k8 positive cancers | |
| IL272081A (en) | Photodynamic therapy method for skin disorders | |
| EP3757187A4 (en) | SURFACE TREATMENT AGENT | |
| PL3288581T3 (pl) | Sposób leczenia nowotworu | |
| HUE053191T2 (hu) | 2-Heteroaril-3-oxo-2,3-dihidropiridazin-4-karboxamidok rák kezelésére | |
| LT4034122T (lt) | Hiperfenilalaninemijos gydymo būdai | |
| IL291170A (en) | Treatment of hr deficient cancer | |
| PT3265087T (pt) | Método de tratamento com tradipitant | |
| IL281600A (en) | Methods of treating cancer | |
| IL308399A (en) | Methods of treating cancer | |
| IL281845A (en) | Combination therapy for the treatment of cancer | |
| SI3576740T1 (sl) | Zdravljenje raka | |
| PL3952858T3 (pl) | Sposób leczenia guzów | |
| EP3576791A4 (en) | CALRETICULIN-MEDIATION CANCER TREATMENT | |
| IL256000A (en) | Quantifying her 2 protein for optimal cancer therapy | |
| IL272379A (en) | Methods of treating cancer by inhibiting setd2 | |
| IL270867A (en) | Treatment method | |
| IL281839A (en) | Treatment methods | |
| IL281792A (en) | Treatment methods | |
| EP4025203A4 (en) | CANCER TREATMENT | |
| IL280968A (en) | Combination therapy |